4-fluoro-N-(3-(5-(2,4,5-trifluoro-3-hydroxybenzoyl)thiophen-2-yl)phenyl)benzenesulfonamide

ID: ALA4441152

PubChem CID: 155515038

Max Phase: Preclinical

Molecular Formula: C23H13F4NO4S2

Molecular Weight: 507.49

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(c1ccc(-c2cccc(NS(=O)(=O)c3ccc(F)cc3)c2)s1)c1cc(F)c(F)c(O)c1F

Standard InChI:  InChI=1S/C23H13F4NO4S2/c24-13-4-6-15(7-5-13)34(31,32)28-14-3-1-2-12(10-14)18-8-9-19(33-18)22(29)16-11-17(25)21(27)23(30)20(16)26/h1-11,28,30H

Standard InChI Key:  BKLGSTICODUCKD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
   27.1200   -4.5111    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.7156   -3.8053    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   26.3066   -4.5085    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.8870   -3.8176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8858   -4.6372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5939   -5.0462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3035   -4.6367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3007   -3.8140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5921   -3.4088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0069   -3.4028    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.4223   -3.3975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1300   -3.8068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8356   -3.3962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8330   -2.5781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1188   -2.1724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4160   -2.5853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1787   -3.4055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0930   -2.5928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2936   -2.4231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8852   -3.1309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4322   -3.7380    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   21.0725   -3.2166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5920   -2.5557    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.7404   -3.9633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9273   -4.0452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5952   -4.7910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0759   -5.4529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8925   -5.3642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2209   -4.6182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4485   -3.3830    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   21.3754   -6.0235    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   19.7447   -6.2000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   18.7825   -4.8763    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.5386   -2.1659    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  8 10  1  0
 10  2  1  0
  2 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 17  1  0
  4 17  1  0
 20 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 25 30  1  0
 28 31  1  0
 27 32  1  0
 26 33  1  0
 14 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4441152

    ---

Associated Targets(Human)

HSD17B2 Tchem Estradiol 17-beta-dehydrogenase 2 (1671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HSD17B1 Tchem Estradiol 17-beta-dehydrogenase 1 (2224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hsd17b2 Estradiol 17-beta-dehydrogenase 2 (138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hsd17b1 Estradiol 17-beta-dehydrogenase 1 (138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 507.49Molecular Weight (Monoisotopic): 507.0222AlogP: 5.71#Rotatable Bonds: 6
Polar Surface Area: 83.47Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 6.17CX Basic pKa: CX LogP: 5.74CX LogD: 4.47
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.20Np Likeness Score: -1.39

References

1. Abdelsamie AS, Salah M, Siebenbürger L, Merabet A, Scheuer C, Frotscher M, Müller ST, Zierau O, Vollmer G, Menger MD, Laschke MW, van Koppen CJ, Marchais-Oberwinkler S, Hartmann RW..  (2019)  Design, Synthesis, and Biological Characterization of Orally Active 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors Targeting the Prevention of Osteoporosis.,  62  (15): [PMID:31343176] [10.1021/acs.jmedchem.9b00932]
2. Abdelsamie AS, Herath S, Biskupek Y, Börger C, Siebenbürger L, Salah M, Scheuer C, Marchais-Oberwinkler S, Frotscher M, Pohlemann T, Menger MD, Hartmann RW, Laschke MW, van Koppen CJ..  (2019)  Targeted Endocrine Therapy: Design, Synthesis, and Proof-of-Principle of 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors in Bone Fracture Healing.,  62  (3): [PMID:30645111] [10.1021/acs.jmedchem.8b01493]

Source